Dr. Reddy’s Laboratories has launched Propofol Injectable Emulsion, a therapeutic equivalent generic version of Diprivan (propofol) Injectable Emulsion, in the U.S. Propofol injectable emulsion is an intravenous general anesthetic and sedation drug, a company release said. The drug major objects to the use of any of its products to facilitate or otherwise aid lethal injections, the release added.
“Consistent with this position, Dr.Reddy’s uses distribution controls to market Propofol Injectable Emulsion. Dr. Reddy’s will not accept orders from correctional facilities and prison systems whose intended use of the product is to aid in lethal injection. We require the same commitment from our wholesalers and distributors,” the company said.
This is a Premium article available exclusively to our subscribers. To read 250+ such premium articles every
month
You have exhausted your free article limit.
Please support quality journalism.
You have exhausted your free article limit.
Please support quality journalism.
The Hindu operates by its editorial values to provide you quality journalism.
You have read {{data.cm.views}} out of {{data.cm.maxViews}} free articles.
This is your last free article.